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The 5-HT7 receptor is one of the several serotonin (5-HT) receptor subtypes
that are expressed in the dorsal raphe nucleus (DRN). Some earlier findings
suggested that 5-HT7 receptors in the DRN were localized on GABAergic interneurons
modulating the activity of 5-HT projection neurons. The aim of the present study
was to find out how the 5-HT7 receptor modulates the GABAergic synaptic input
to putative 5-HT DRN neurons, and whether blockade of the 5-HT7 receptor
would affect the release of 5-HT in the target structure. Male Wistar rats with
microdialysis probes implanted in the prefrontal cortex (PFC) received injections
of the 5-HT7 receptor antagonist (2R)-1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-
piperidinyl)ethyl]pyrrolidine hydrochloride (SB 269970), which induced an increase in
the levels of 5-HT and its metabolite, 5-hydroxyindoleacetic acid (5-HIAA) in the
PFC. In another set of experiments whole-cell recordings from presumed projection
neurons were carried out using DRN slices. SB 269970 application resulted in
depolarization and in an increase in the firing frequency of the cells. In order to
activate 5-HT7 receptors, 5-carboxamidotryptamine (5-CT) was applied in the presence
of N-[2-[4-(2-methoxyphenyl)-1piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamide
(WAY100635). Hyperpolarization of cells and a decrease in the firing frequency were
observed after activation of the 5-HT7 receptor. Blockade of 5-HT7 receptors caused
a decrease in the mean frequency of spontaneous inhibitory postsynaptic currents
(sIPSCs), while its activation induced an increase. The mechanism of these effects
appears to involve tonically-active 5-HT7 receptors modulating firing and/or GABA
release from inhibitory interneurons which regulate the activity of DRN serotonergic
projection neurons.
Keywords: brain slices, HPLC, microdialysis, prefrontal cortex, whole-cell recording
Abbreviations: 5-CT, 5-carboxamidotryptamine; 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, 5-hydroxytryptamine,
serotonin; ACSF, artificial cerebrospinal fluid; DRN, dorsal raphe nucleus; SB 269970, (2R)-1-[(3-hydroxyphenyl)sulfonyl]-
2-[2-(4-methyl-1-piperidinyl)ethyl] pyrrolidine hydrochloride; sIPSC, spontaneous inhibitory postsynaptic current; WAY
100635, N-[2-[4-(2-methoxyphenyl)-1piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamide.
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Introduction
The dorsal raphe nucleus (DRN) is the main source of
widespread serotonin (5-hydroxytryptamine, 5-HT) projections
to the forebrain, which regulate the activity of neuronal circuits
involved in a spectrum of functions including emotional states,
sleep, motivation and aggression (reviewed in Celada et al.,
2013; Paul and Lowry, 2013). DRN 5-HT projection neurons
have been thoroughly studied (reviewed in Aghajanian et al.,
1990; Gaspar and Lillesaar, 2012; Andrade and Haj-Dahmane,
2013). These cells exhibit in vivo a regular, slow activity pattern
and fire broad (2–3 ms) action potentials which are generated
by a combination of voltage-dependent sodium and calcium
conductances (Penington et al., 1991; Beck et al., 2004). DRN
also contains numerous nonserotonergic neurons which release
glutamate, GABA, as well as dopamine and peptide transmitters
(Kirby et al., 2003; reviewed in Liu et al., 2000; Commons, 2009;
Soiza-Reilly and Commons, 2014). Some of these cells are local
interneurons (Commons, 2009; Calizo et al., 2011); however,
recent work has demonstrated that many DRN projection
neurons are glutamatergic or GABAergic (Jackson et al., 2009;
Bang and Commons, 2012). Moreover, subsets of DRN 5-
HT neurons coexpress glutamate or GABA (Commons, 2009;
Shikanai et al., 2012).
The activity of DRN neurons is modulated by the locally
released 5-HT (Hernandez-Lopez et al., 2013). Serotonin
receptors in the central nervous system have been classified
as members of seven families and at least 15 subtypes on
the basis of their pharmacological properties, their coupling to
intracellular signaling cascades and the protein structure (Hoyer
et al., 2002). DRN 5-HT neurons have been found to express
5-HT1A, 5-HT1B, 5-HT1D and possibly, 5-HT2 autoreceptors
(McDevitt and Neumaier, 2011). Another receptor, abundant
in the DRN, is the 5-HT7 one (Roberts et al., 2001). Beside
the DRN, high levels of 5-HT7 receptor mRNA and protein
are present in the thalamus, hippocampus, frontal cortex and
hypothalamus (reviewed in Hedlund and Sutcliffe, 2004). This
receptor stimulates adenylyl cyclase via Gαs proteins and is
also coupled to the G12 protein; and moreover, it activates
small GTPases of the Rho family (reviewed in Gellynck et al.,
2013; Guseva et al., 2014). Activation of the 5-HT7 receptor
increases the excitability of the neuron that expresses it (Bacon
and Beck, 2000; Bickmeyer et al., 2002; Tokarski et al., 2003).
A considerable body of experimental evidence indicates that
the 5-HT7 receptor may be involved in the etiology of mental
illnesses (reviewed in Hedlund, 2009; Ciranna and Catania,
2014). Also, recent research has suggested that the antagonists
of this receptor may constitute a new class of antidepressant
drugs with a faster therapeutic action than that of the currently
used drugs (Mnie-Filali et al., 2011; reviewed in Tokarski et al.,
2012).
It has been reported that administration of the 5-HT7
receptor agonist AS19 results in a reduction in the firing
rate of rat DRN 5-HT cells in vivo (Mnie-Filali et al., 2011).
On the other hand, blockade of the 5-HT7 receptor by
the selective antagonist (2R)-1-[(3-hydroxyphenyl)sulfonyl]-2-
[2-(4-methyl-1-piperidinyl)ethyl]pyrrolidine hydrochloride (SB
269970; Hagan et al., 2000) has been shown to increase the
extracellular level of 5-HT in the prefrontal cortex (PFC;
Wesołowska and Kowalska, 2008; but see Bonaventure et al.,
2007). These findings are consistent with the hypothesis that
5-HT7 receptors in the DRN are not localized on 5-HT
cells, but rather on local GABAergic interneurons which
modulate the activity of 5-HT projection neurons (Harsing,
2006). The 5-HT7 receptor-dependent modulation of inhibitory
influence on DRN projection neurons is has not yet been
explored (Liu et al., 2000; Gocho et al., 2013; Weissbourd
et al., 2014; Commons, 2015). Therefore, in the present
study we aimed at determining how the 5-HT7 receptor
activation and blockade modulate the GABAergic synaptic
input to electrophysiologically identified, broad action potential-
exhibiting DRN neurons in a slice preparation. We have
also investigated, whether blockade of the 5-HT7 receptor
would influence the extracellular level of 5-HT and its
metabolite 5-hydroxyindoleacetic acid (5-HIAA) in the PFC
in vivo.
Materials and Methods
Animals
All experimental procedures were approved by the Local
Ethics Committee for Animal Experiments at the Institute of
Pharmacology, Polish Academy of Sciences, and were carried
out in accordance with the European Community guidelines
for the use of experimental animals and the national law. Male
Wistar rats (Charles River, Germany) were housed in groups in
standard laboratory cages and kept in a constant temperature-
and humidity-controlled colony room (21 ± 2◦C) on a 12 h
light/dark cycle (the light on at 07:00, off at 19:00). Commercial
food and tap water were available ad libitum.
Microdialysis
Rats (250–300 g) were anaesthetized with ketamine (75 mg/kg
IM) and xylazine (10 mg/kg IM) and put in a stereotaxic
apparatus (David Kopf Instruments, USA). The scalp was
retracted and holes were drilled through the skull to insert
vertical microdialysis probes into the PFC (2.9 mm anterior from
the bregma, 0.8 mm lateral from the sagittal suture and −4.5
ventral from the dural surface; Paxinos and Watson, 1998). The
microdialysis probes were constructed by inserting two fused
silica tubes (30 and 35 mm long, 150 µm outer diameter (o.d.);
Polymicro Technologies Inc., USA) into a microdialysis fiber
(220 µm o.d.; AN69, Hospal, Italy). The tube assembly was
placed in a stainless steel cannula (22 gauge, 10 mm) making
the shaft of the probe. Parts of inlet and outlet tubes were
individually placed inside the polyethylene PE-10 tubing and
glued for protection. The free end of the dialysis fiber was sealed,
and its 3 mm exposed length was used for a dialysis in the PFC.
One day after probe implantation, the inlet of the dialysis probe
was connected to a syringe pump (BAS, USA) which delivered
an artificial cerebrospinal fluid (ACSF) composed of (in mM):
NaCl (145), KCl (4), MgCl2 (1), CaCl2 (2.2); pH = 7.4 at a
flow rate of 2.0 µl/min. After a 2 h rinsing period, baseline
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samples (3–4) were collected every 20 min. SB 269970 (1.25 or
2.5 mg/kg) was dissolved in a 0.9% saline and injected in a volume
of 4 ml/kg IP. Samples were collected every 20 min for 4 h.
At the end of the experiment the rats were sacrificed and their
brains were histologically examined to validate the correct probe
placement.
5-HT and 5-HIAA levels were analyzed by HPLC with a
coulochemical detection. Chromatography was performed using
the Ultimate 3000 System (Dionex, USA), the coulochemical
detector Coulochem III (model 5300, ESA, USA) with the 5020
guard cell, the 5014B microdialysis cell and the Hypersil Gold-
C18 analytical column (3 × 100 mm). The mobile phase was
composed of 0.05 M potassium phosphate buffer adjusted to
pH = 3.9, 0.5 mM EDTA, 13 mg/L 1-octanesulfonic acid sodium
salt, a 3.1% methanol and a 0.93% acetonitrile. The flow rate
during the analysis was 0.7 ml/min. The applied potential of
a guard cell was +600 mV, while those of a microdialysis cell
were E1 = −50 mV and E2 = +300 mV and a sensitivity was
set at 50 nA/V. The chromatographic data were processed by
the Chromeleon v. 6.80 (Dionex, USA) software run on a PC
computer. The values were not corrected for an in vitro probe
recovery which was ca. 15%.
Slice Preparation and Incubation
Rats (150 g) were decapitated under isoflurane anesthesia
(Aerrane, Baxter, UK), their brains were quickly removed and
placed in an ice-cold modified ACSF containing (in mM):
NaCl (130), KCl (5), CaCl2 (2.5), MgSO4 (1.3), KH2PO4 (1.25),
NaHCO3 (26) and D-glucose (10), bubbled with the mixture of
95% O2–5% CO2. Coronal midbrain slices containing the DRN
(300 µm thick) were cut using a vibrating microtome (VT1000,
Leica, Germany). Two slices were obtained from one animal.
Slices were then stored submerged in ACSF at 30± 0.5◦C.
An individual slice was placed in the recording chamber,
being superfused at 3 ml/min with warm (32 ± 0.5◦C), modified
ACSF of the following composition (in mM): NaCl (132),
KCl (2), KH2PO4 (1.25), NaHCO3 (26), MgSO4 (1.3), CaCl2
(2.5), D-glucose (10), bubbled with 95% O2–5% CO2. Neurons
were visualized using the Axioskop 2 (Zeiss, Germany) upright
microscope with the Nomarski optics, a 40× water immersion
lens and an infrared camera (Tokarski et al., 2007).
Analysis of Intrinsic Excitability and Inhibitory
Postsynaptic Currents
Patch pipettes were pulled from borosilicate glass capillaries
using the Sutter Instrument P97 puller. The pipette solution
contained (in mM): K-gluconate (130), NaCl (5), CaCl2 (0.3),
MgCl2 (2), HEPES (10), Na2-ATP (5), Na-GTP (0.4) and EGTA
(1). Osmolarity and pH were adjusted to 290 mOsm and 7.2,
respectively. Pipettes had an open tip resistance of approximately
6 MΩ.
Whole-cell recordings were obtained from presumed 5-HT
DRN neurons which were identified on the basis of their response
to hyper- and depolarizing current pulses (Figures 1A,B; cf.
Galindo-Charles et al., 2008). Cells were sampled from the dorsal
part of the midline region of the DRN. Signals were recorded
using the SEC 05LX amplifier (NPI, Germany), filtered at 2
kHz and digitized at 20 kHz using the Digidata 1440 interface
and pClamp 10 software (Molecular Devices, USA). An input-
output relationship was assessed in the current-clamp mode
using hyper- and depolarizing current pulses (500 ms). To assess
the relationship between the injected current and the spiking
rate (gain) depolarizing current was increased in 20 pA steps,
delivered every 2 s. The width of the action potential was
measured at the threshold, which was determined according to
Henze and Buzsáki (2001).
To record spontaneous inhibitory postsynaptic currents
(sIPSCs), neurons were voltage-clamped at 0 mV (Tokarski
et al., 2007). After 15 min of the stabilization period
the baseline sIPSCs activity was recorded for 4 min. To
block the 5-HT7 receptor, its selective antagonist SB 269970
(Hagan et al., 2000) was then added to the ASCF and
after next 15 min of stabilization sIPSCs were recorded for
4 min. In the experiments involving activation of the 5-HT7
receptor slices were incubated in the ACSF supplemented
with N-[2-[4-(2-methoxyphenyl)-1piperazinyl]ethyl]-N-2-pyrid
inylcyclohexanecarboxamide (WAY100635, 2 µM, a selective
5-HT1A antagonist; Mundey et al., 1996; Tokarski et al., 2003).
After obtaining whole-cell configuration, the stabilization period
(15 min) and the baseline recording (4 min), 200 nM 5-CT (a
nonselective agonist) was added to the ACSF. After the following
15 min of stabilization sIPSCs were recorded for 4 min. Data
were accepted for analysis when the access resistance ranged
between 15 and 18 MΩ and it was stable during recordings.
The recordings were inspected off-line using the Mini Analysis
software (Synaptosoft) and individual synaptic events were
selected manually for further analysis.
Statistical Analysis
The results are expressed as the mean ± SEM unless otherwise
noted. The statistical significance of the microdialysis data
was calculated using repeated-measures ANOVA, followed by
Tukey’s post hoc test, if applicable. Statistical analyses of the
electrophysiological data were carried out using paired Student’s
t-tests, Wilcoxon signed-rank test and Kolmogorov-Smirnov
test, where applicable.
Results
The 5-HT7 Receptor Antagonist SB 269970
Induces 5-HT Release in the Prefrontal Cortex
In Vivo
The basal concentrations of 5-HT in dialysates from the
PFC were 1.29 ± 0.19 pg/10 µl, 1.18 ± 0.16 pg/10 µl and
0.91 ± 0.09 pg/10 µl in the control group, in rats receiving
1.25 mg/kg SB 269970 and in rats receiving 2.5 mg/kg SB
269970, respectively. Those differences were not statistically
significant. Injections of SB 269970 increased the extracellular
level of 5-HT, which reached approximately 300% of the basal
level at the higher dose of the drug during the first hour
after its injection (Figure 2A). No difference in 5-HT level
increase between both doses of SB 269970 was observed between
90–240 min after the administration of the drug. A significant
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FIGURE 1 | Electrophysiological properties of sampled dorsal
raphe nucleus (DRN) neurons. (A) An image of a DRN slice (DIC
optics) showing a presumed projection cell (an arrow) before the start
of the recording. (B1) Responses of a presumed projection neuron to
a series of hyper- and depolarizing current pulses. (B2) Upper trace, a
single action potential shown at an expanded timescale with a “notch”
(indicated with an asterisk) on the descending phase. A horizontal
double arrow indicates the way the action potential width was
measured. Lower trace, the first derivative of action potential waveform
emphasizes a “notch” (an asterisk). (C) Responses of a presumed
non-5-HT interneuron to a series of hyper- and depolarizing current
pulses.
FIGURE 2 | The effect of SB 269970 on the extracellular levels of 5-HT
(A) and 5-HIAA (B) in the prefrontal cortex (PFC) of freely moving rats.
Graphs represent plots of the mean normalized values (± SEM). Gray circles:
1.25 mg/kg SB 269970 (n = 5); black circles: 2.5 mg/kg SB 269970 (n = 6);
open circles: control animals receiving saline (n = 6). *p < 0.05; **p < 0.01.
Time 0 corresponds to the time of injection (an arrow).
effect of treatment with SB 269970 on 5-HT level was observed
(ANOVA, F(2,17) = 12.18, p < 0.0005). There was no effect
of time (ANOVA, F(7,119) = 1.16, p < 0.33) and there was
no interaction between both factors (ANOVA, F(14,119) = 1.59,
p< 0.09).
The basal concentrations of 5-HIAA were 677 ± 22 pg/10 µl,
600 ± 37 pg/10 µl and 607 ± 30 pg/10 µl in the control
group, in rats receiving 1.25 mg/kg SB 269970 and in rats
receiving 2.5 mg/kg SB 269970, respectively. There were no
significant differences between the groups. SB 269970 increased
the extracellular level of 5-HIAA only at the higher dose with the
maximum reaching approximately 138% of the basal level 60 min
after administration (Figure 2B). This effect corresponded to
an increase in the extracellular level of 5-HT but it occurred
about 30 min later. A significant effect of treatment with the
drug on 5-HIAA (ANOVA, F(2,17) = 7.56, p < 0.004), as
well as a significant effect of time (ANOVA, F(7,119) = 14.73,
p < 0.0001) and an interaction between both those factors
(ANOVA, F(14,119) = 8.00. p< 0.0001) were observed.
The 5-HT7 Receptor Antagonist SB 269970
Enhances Spiking Activity and Reduces the
Inhibitory Input to Neurons in DRN Slices
In response to depolarizing current pulses (500 ms), all the
cells subjected to the analysis showed adaptation of the firing
frequency (Figure 1B1). In the case of stronger current pulses
(500–600 pA), an average firing frequency reached 12–16 Hz.
Their action potentials were broad (3.66 ± 0.06 ms) and they
showed a characteristic inflection during the descending phase
of the spike (Figure 1B2). The mean input resistance of those
cells was 432.13 ± 23.55 M, and they showed no spontaneous
spiking activity at the resting membrane potential (−64.5 ±
3.4 mV). As illustrated in Figure 1C, presumed non-5-HT DRN
neurons exhibited higher firing frequencies (range: 36–42 Hz)
and lower input resistance (260.12 ± 20.32 M) than presumed
5-HT cells (cf. Galindo-Charles et al., 2008).
A sample of cells (n = 11; 6 animals) was depolarized in
the current-clamp mode to either −50 or −45 mV by current
injection (15–55 pA) to induce sustained firing (Figure 3A).
In order to study the effect of 5-HT7 receptor blockade on
depolarization-induced sustained activity, SB 269970 (2.5 µM)
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was added to the ACSF, which resulted in further depolarization
of the cells by 4.9 ± 0.5 mV (n = 11; 6 animals, paired t-test,
t = −5.012, df = 10, p < 0.001; Figures 3A,B) and in an increase
in the sustained firing frequency up to 182± 24% of the baseline
(n = 11; 6 animals, paired t-test, t = −4.418, df = 10, p = 0.002;
Figure 3C). The blockade of 5-HT7 receptors did not modify
the excitability of DRN neurons (n = 6; 3 animals, paired t-test,
t = 0.702, df = 5, p = 0.514; Figures 3E,F). No change in
the sustained spiking frequency occurred when the membrane
potential was adjusted to the baseline level with a steady current
injection (n = 9; 5 animals, paired t-test, t = −1.411, df = 8,
p = 0.196; Figure 3C). No change in the sustained spiking
frequency and no depolarization occurred when SB 269970
(2.5 µM) was added to the ACSF supplemented with 10 µM
bicuculline to block GABAA receptors and with 2 mM kynurenic
acid to block the excitatory transmission (Figures 3C,D; n = 5;
3 animals; spiking frequency: paired t-test, t = −1.5, df = 4,
p = 0.208; membrane potential: paired t-test, t = −0.535 df = 4,
p = 0.621).
A separate sample of presumed DRN projection neurons
(n = 11, 6 animals) was voltage-clamped at 0 mV to record
spontaneous IPSCs (Figure 4A). The mean frequency and mean
amplitude (± SEM) of sIPSCs during baseline recordings were
0.751 ± 0.084 Hz and 26.89 ± 1.36 pA, respectively. Addition
of SB 269970 (2.5 µM) to the ACSF resulted in a decrease in
the mean frequency of sIPSCs to 0.663 ± 0.0821 Hz (Wilcoxon
signed-rank test, p < 0.001; Figures 4B,C). The mean amplitude
of sIPSCs remained unchanged (Wilcoxon signed-rank test,
26.66± 1.33 pA; p = 0.07; Figure 4C).
Activation of the 5-HT7 Receptor Suppresses
Spiking Activity and Enhances the Inhibitory
Input to Neurons in DRN Slices
A group of cells (n = 10; 5 animals) was depolarized
in the current-clamp mode by current injection (25–40
pA) to induce sustained firing (Figure 5A). To activate
the 5-HT7 receptor, 250 nM 5-CT (a nonselective agonist)
was added to the ACSF supplemented with N-[2-[4-(2-
methoxyphenyl)-1piperazinyl]ethyl]-N-2- pyridinylcyclohexane
carboxamide (WAY100635, 2µM, a selective 5-HT1A antagonist;
Tokarski et al., 2003). Hyperpolarization of the cells by 4.4 ±
1.1 mV (n = 10; 5 animals; paired t-test, t = 2.857 df = 9,
p = 0.019; Figures 5A,B) and a decrease in the sustained firing
frequency to 76.5 ± 3.9% of the baseline (n = 10; 5 animals,
paired t-test, t = 5.432, df = 9, p = 0.002; Figure 5C) were
observed. Activation of the 5-HT7 receptor did not modify
the excitability of DRN neurons (n = 8; 4 animals; paired t-
test, t = 1.09, df = 7, p = 0.312; Figures 5E,F). No change in
the sustained spiking frequency occurred when the membrane
potential was adjusted to the baseline level with a steady current
injection (n = 8; 4 animals, paired t-test, t = −1.83, df = 7,
p = 0.11; Figure 5C). No change in the sustained spiking
frequency and no depolarization occurred when 5-CT (250 nM)
was added to the ACSF supplemented with 10 mM bicuculline
to block GABAA receptors and with 2 mM kynurenic acid
to block the excitatory transmission (Figures 5C,D; n = 5; 3
FIGURE 3 | The effect of SB 269970 (2.5 µM) on the spiking activity of
DRN neurons. (A) A representative example of the sustained spiking activity
of a cell (previously depolarized to −50 mV) before (Con.) and 15 min after the
addition of SB 269970 (SB) to the artificial cerebrospinal fluid (ACSF). Action
potentials are truncated. (B) SB 269970-induced changes in the membrane
potential. Neurons were initially depolarized to −50 or −45 mV to induce
sustained firing. (C) An increase in the spiking frequency is absent after
adjustment of the membrane potential of a neuron to the baseline values to
prevent SB 269970-induced depolarization and in the presence of bicuculline.
Shown are mean values (± SEM) of changes in the spiking frequency of cells
depolarized (Dep., n = 11) by SB 269970, in a sample of cells whose
membrane potential was adjusted (Adj., n = 9) to the baseline values and in a
sample of cells (n = 5) recorded in the presence of 10 µM bicuculline (Bic.)
and 2 mM kynurenic acid. (D) No significant change in the membrane
potential was found when SB 269970 was applied in the presence of 10 µM
bicuculline (Bic.) and 2 mM kynurenic acid (n = 5). (E1) Responses of a
representative cell to a depolarizing current pulse before (Con.) and after
addition of SB 269970 (SB). (E2) The relationship between the injected current
vs. the spiking rate of the cell shown in (E1) before (white circles) and after
(black circles) addition of SB 269970. The lines represent a linear regression.
(F) A comparison of the relationship between the injected current and the
firing rate (gain). Mean values ± SEM are shown. *p < 0.001.
animals; spiking frequency: paired t-test, t = 1.195, df = 4,
p = 0.298; membrane potential: paired t-test, t = 0.667, df = 4,
p = 0.541).
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FIGURE 4 | The effect of SB 269970 (2.5 µM) on spontaneous
IPSCs. (A) Sample recordings from a representative neuron before
(Con.) and 15 min after SB 269970 (SB) addition to the ACSF.
Spontaneous events were blocked after addition of bicuculline
methiodide (Bic., 10 µM). (B) Cumulative probability plots of
inter-event interval (upper graph) and amplitude (lower graph) of
sIPSCs recorded from a representative cell before (Con.) and after
(SB) addition of SB 269970. The difference between the
distributions of inter-event interval, but not amplitude, is significant
(p = 0.0003 vs. p = 0.548, respectively, Kolmogorov-Smirnov test).
(C) SB 269970—induced a small but significant decrease in the
frequency (upper graph, *p < 0.001; Wilcoxon signed-rank test) but
not amplitude of sIPSCs (lower graph, p = 0.07; Wilcoxon
signed-rank test).
A separate sample of presumed DRN projection neurons
(n = 33, 17 animals) was voltage-clamped at 0 mV to record
sIPSCs (Figure 6A). As shown in Figures 6B,C and Table 1,
addition of 5-CT (50–500 nM) to the ACSF resulted in a dose-
dependent increase in the mean frequency of sIPSCs.
Discussion
The results of the present study indicate that blockade of the
5-HT7 receptor enhances the release and metabolism of 5-HT in
the PFC. This effect appears to be mediated by the depolarization
and enhanced firing of DRN serotonergic projection neurons,
resulting from a decreased inhibitory synaptic input received by
the projection cells. In contrast, activation of the 5-HT7 receptor
increases the frequency of spontaneous IPSCs, which results
in hyperpolarization and reduced firing of the putative DRN
projection cells.
The present results confirm and extend an earlier report that
showed that blockade of the 5-HT7 receptor with low doses
of SB 269970 (0.625 and 1.25 mg/kg) resulted in an increase
in the level of extracellular 5-HT (Wesołowska and Kowalska,
2008). The effect of a higher dose of SB 269970 (2.5 mg/kg),
used in the present study, was more potent, but only during
the first hour after the administration. This result points to the
activation of mechanisms which do not allow for an excessive
tonic release of 5-HT from cortical terminals. An increase in
the level of 5-HIAA is consistent with an increased level of
5-HT in the extracellular space. Another study demonstrated
that SB 269970 administered in a dose of 10 mg/kg did not
increase the extracellular concentration of 5-HT in the rat frontal
cortex (Bonaventure et al., 2007). A most likely explanation of
such an apparent discrepancy is the way of drug administration:
intraperitoneal (Wesołowska and Kowalska, 2008 and our study)
vs. subcutaneous (Bonaventure et al., 2007).
All the examined cells showed a low frequency, rhythmic
activity after moderate depolarization, broad action potentials,
adaptation of the firing frequency during depolarizing steps and
an inflection on the descending phase of the spike (cf. Galindo-
Charles et al., 2008). Those features were originally considered
to be unique to DRN 5-HT neurons (Aghajanian et al., 1990).
Later on it was shown that the population of DRN neurons with
similar characteristics included non-serotonergic cells; however,
there may be subtle differences between these neurons regarding
e.g., the timecourse of the afterhyperpolarization (Kirby et al.,
2003). We did not carry out an immunohistochemical analysis
of the recorded cells, however, other investigators found that
86% of the population of identified, 5-HT-immunoreactive
DRN neurons exhibited the inflection on the action potential
descending phase and other features characteristic of the cell type
we recorded from (Galindo-Charles et al., 2008). Some 5-HT
cells also coexpress the GABAergic marker GAD67 (Shikanai
et al., 2012), but ‘‘pure’’ DRN GABAergic interneurons, that do
not synthesize 5-HT show different activity patterns, including
short spikes and considerably higher discharge frequencies
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FIGURE 5 | The effect of 5-CT (250 nM), applied in the presence of
WAY100635 (2 µM) on the spiking activity of DRN neurons. (A) An
example of the sustained spiking activity of a cell (previously depolarized to
−50 mV) before (Con.) and 15 min after addition of 5-CT to the ACSF. Action
potentials are truncated. (B) The 5-CT—induced changes in the membrane
potential of the investigated sample of cells. Neurons were initially depolarized
to induce sustained firing. (C) A decrease in the spiking frequency is absent if
the membrane potential of a cell is adjusted to the baseline values to prevent
hyperpolarization. Mean (± SEM) changes in the spiking frequency of cells
hyperpolarized (Hyp., n = 10) by 5-CT, in a sample of cells whose membrane
potential was adjusted (Adj., n = 8) and in a sample of cells (n = 5) recorded in
the presence of 10 µM bicuculline (Bic.) and 2 mM kynurenic acid. (D) No
significant change in the membrane potential was found when 5-CT was
applied in the presence of 10 µM bicuculline (Bic.) and 2 mM kynurenic acid.
(E1) Responses of a representative neuron to a depolarizing current pulse
before (Con.) and after addition of 5-CT (5-CT). (E2) The relationship between
the injected current vs. the spiking rate of the cell shown in (E1) before (white
circles) and after (black circles) addition of 5-CT. The lines represent a linear
regression. (F) A comparison of the relationship between the injected current
and the firing rate (gain). Mean values ± SEM are shown. *p < 0.01.
(Galindo-Charles et al., 2008; Shikanai et al., 2012; Gocho et al.,
2013). Therefore it may be assumed that a significant fraction
of the cells recorded throughout the present study represented
5-HT projection cells. The excitability of these neurons was not
directly influenced by the activation or blockade of the 5-HT7
receptor.
It has been established that DRN neurons receive GABAergic
inputs from extrinsic sources, including the hypothalamus,
substantia nigra, ventral tegmental area and rostromedial
tegmental nucleus (reviewed in Soiza-Reilly and Commons,
2011). Since the axons from these structures are cut during slice
preparation, their contribution to the observed effects seems
unlikely.
5-HT had previously been shown to induce a concentration-
dependent increase in the frequency of sIPSCs recorded from
the putative serotonergic neurons in DRN slices (Liu et al.,
2000). The latter effect was shown to be mediated by local
GABAergic interneurons, since it was blocked by the inhibitor
of voltage-gated sodium channels tetrodotoxin. The stimulatory
effect of 5-HT on GABAergic interneurons was attributed to
the activation of 5-HT2A and 5-HT2C receptors; however, even
high concentrations of the antagonist of those receptors did not
completely block the effects of 5-HT application (Liu et al., 2000;
Gocho et al., 2013).
To activate the 5-HT7 receptor we have applied a nonselective
agonist, 5-CT, in the presence of WAY100636, a selective
antagonist of the 5-HT1A receptor (Mundey et al., 1996). 5-CT
has been reported to be an agonist of 5-HT1A, 5-HT1B, 5-HT1D
and 5-HT7 receptors. However, the affinity of 5-CT to the 5-HT7
receptor is one order of magnitude higher than to the 5-HT1B and
5-HT1D receptors.1 Moreover, activation of the 5-HT1B receptor
has been reported to increase the firing of DRN 5-HT neurons via
a reduction of the inhibitory inputs (Adell et al., 2001). Thus, the
effects of 5-CT observed in the present study (increased sIPSCs
frequency, hyperpolarization and reduced firing of presumable
5-HT cells) is consistent with the activation of the 5-HT7
receptor located on GABAergic interneurons. This conclusion
is supported by the observation that blockade of the 5-HT7
receptor induces opposite phenomena. The observed effects of
application of the 5-HT7 receptor antagonist indicate that the
receptors are tonically active most likely due to locally released
5-HT. We showed previously that activation of 5-HT7 receptors
resulted in the enhancement of GABAergic transmission in the
hippocampal CA1 area, at least partially via 5-HT7 receptors
located on inhibitory interneurons (Tokarski et al., 2011).
The 5-HT7 receptor is implicated in a wide range of
pathological processes; in particular, its selective blockade has
been shown to induce antidepressant-like effects in animal
models (reviewed in Ciranna and Catania, 2014; Nikiforuk,
2015). The above data point to a plausible cellular mechanism
of the antidepressant action of 5-HT7 receptor antagonists.
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FIGURE 6 | The effect of 5-CT on spontaneous IPSCs.
(A) Recordings from a representative neuron before (Con) and 15 min
after addition of 250 nM 5-CT (in the presence of 2 µM WAY100635) to
the ACSF. Spontaneous events were blocked after addition of bicuculline
methiodide (Bic, 10 µM). (B) Cumulative probability plots of inter-event
interval (upper graph) and amplitude (lower graph) of sIPSCs recorded
from a representative cell before (Con.) and after (SB) addition of 250 nM
5-CT. The difference between the distributions of inter-event interval, but
not amplitude, is significant (p < 0.001 vs. p = 0.412, respectively,
Kolmogorov-Smirnov test). (C) 5-CT (150–500 nM) induced an increase
in the frequency (upper graph) but not amplitude of sIPSCs (lower graph).
*p < 0.005; Wilcoxon signed-rank test.
TABLE 1 | The effect of 5-CT on spontaneous IPSCs.
5-CT Mean control Mean frequency Mean control Mean amplitude Number
concentration (nM) frequency (Hz) in 5-CT (Hz) amplitude (pA) in 5-CT (pA) of cells
50 0.72 ± 0.15 0.69 ± 0.16 26.90 ± 1.90 26.53 ± 1.93 6
150 0.60 ± 0.14 0.75 ± 0.15* 28.22 ± 1.37 28.56 ± 1.41 13
250 0.64 ± 0.15 1.03 ± 0.17* 24.23 ± 1.56 24.34 ± 1.52 8
500 0.52 ± 0.07 1.00 ± 0.11* 28.91 ± 1.76 29.61 ± 2.30 6
Data were acquired before (control) and 15 min after addition of 5-CT (in the presence of 2 µM WAY100635) to the ACSF. *p < 0.005. Wilcoxon signed-rank test.
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